Home/Filings/4/0001104659-24-127237
4//SEC Filing

Myers Michael 4

Accession 0001104659-24-127237

CIK 0001671502other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:47 PM ET

Size

6.0 KB

Accession

0001104659-24-127237

Insider Transaction Report

Form 4
Period: 2024-12-09
Myers Michael
DirectorChief Executive Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2024-12-09+536,603536,603 total
    Exercise: $0.78Exp: 2034-12-09ADS (536,603 underlying)
Footnotes (2)
  • [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
  • [F2]The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028.

Issuer

Quoin Pharmaceuticals, Ltd.

CIK 0001671502

Entity typeother

Related Parties

1
  • filerCIK 0001959547

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:47 PM ET
Size
6.0 KB